Horm Metab Res 1988; 20(4): 225-229
DOI: 10.1055/s-2007-1010799
Clinical

© Georg Thieme Verlag, Stuttgart · New York

Aberrant Production and Regulation of Proopiomelanocortin-Derived Peptides in Ectopic Cushing's Syndrome

K. A. Roth1 , D. C. Newell2 , R. I. Dorin2 , J. H. Eberwine3 , A. R. Hoffman2
  • 1Department of Pathology, Washington University School of Medicine, St. Louis, Missouri
  • 2Department of Medicine, Stanford University Medical Center, Stanford, California, U.S.A.
  • 3The Nancy Pritzker Laboratory of Behavioral Neurochemistry, Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, California, U.S.A.
Further Information

Publication History

1987

1987

Publication Date:
14 March 2008 (online)

Summary

A 64 year old woman with a pancreatic islet cell tumor developed Cushing's syndrome. Glucocorticoid secretion did not decrease after low or high dose dexamethasone administration, and the Cushing's syndrome was cured by removal of tumor tissue. Immunohistochemistry and radioimmunoassays revealed the presence of immunoreactive ACTH, β-endorphin and α-MSH in the tumor cells. Gel-permeation chromatography confirmed that β-endorphin was the predominant opioid peptide produced by the tumor. The tumor was shown to contain a single 1.2 kilobase RNA species which hybridized to a 32P human POMC-cDNA; this POMC RNA was identical in size to that isolated from a normal human pituitary. In dispersed monolayer culture, CRF failed to elicit ACTH release from the tumor cells, but dexamethasone caused a paradoxical increase in ACTH secretion in vitro. This study demonstrates that aberrant regulation of POMC synthesis and peptide processing can be seen in tumors which synthesize a POMC RNA identical in size to that made in the pituitary gland.